Article
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Brain : a journal of neurology - 1 Jun 2012
Petratos Steven, Ozturk Ezgi, Azari Michael F, Kenny Rachel, Lee Jae Young, Magee Kylie A, Harvey Alan R, McDonald Courtney, Taghian Kasra, Moussa Leon, Mun Aui Pei, Siatskas Christopher, Litwak Sara, Fehlings Michael G, Strittmatter Stephen M, Bernard Claude C A
Abstract excerpt
Multiple sclerosis involves demyelination and axonal degeneration of the central nervous system. The molecular mechanisms of axonal degeneration are relatively unexplored in both multiple sclerosis and its mouse model, experimental autoimmune encephalomyelitis. We previously reported that targeting the axonal growth inhibitor, Nogo-A, may protect against neurodegeneration in experimental autoimmune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
